Indicator summary: Leaning bearish (2 bullish, 3 bearish, 0 neutral). As of 2026-11-05, the close was $120.37: 40.8% below the 50-day average and 32.5% below the 200-day average, which is rising. RSI (14) is 30, oversold. MACD is bearish. The stock sits 21% of the way up its 52-week range of $73.52 to $299.86, on 2.0x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $203.48 | Price 40.8% below |
| 200-day average | $178.21 | Price 32.5% below, average rising |
| 50 vs 200-day | 50 above 200 | Golden-cross alignment |
| RSI (14) | 30 | Oversold |
| MACD (12, 26, 9) | -20.01 vs -16.80 | Line below signal |
| 52-week range | $73.52 to $299.86 | 21% of the way up the range |
| Volume vs 20-day average | 2.0x | Heavy |
Base rates use NBIS's own daily history since 2011; they describe the past, not a forecast.
As of 2026-11-05, NBIS's 14-day RSI is 30, which is oversold (below 30). When it had RSI below 30 (691 days), it was higher 63 trading days later 16% of the time, median +0.0%.
No. NBIS closed at $120.37 on 2026-11-05, 32.5% below its 200-day average of $178.21, which is rising. When it closed below its 200-day average (1,536 days), it was higher 63 trading days later 39% of the time, median +0.0%.
No. NBIS closed at $120.37 on 2026-11-05, 40.8% below its 50-day average of $203.48. When it closed below its 50-day average (1,894 days), it was higher 63 trading days later 48% of the time, median +0.0%.
No cross in the last 10 trading days. As of 2026-11-05 the MACD line is -20.01 against a signal line of -16.80, so MACD is bearish.
No. At $120.37 it sits 21% of the way up its 52-week range of $73.52 to $299.86, 59.9% below the high.
Leaning bearish: 2 of 5 indicators are bullish and 3 bearish as of 2026-11-05 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Bullish, from the chart signal model.
NBIS analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.